In breast cancer cells it also works as a receptor for uPA [134], suggesting a model in which CK8, in complex with uPA, plasminogen and fibronectin constitutes a signaling platform capable of modulating cell adhesion and growth. The gene discussed is KRT8; the disease is breast carcinoma.